Get the Stockscreener App
5.72
5.45%
-0.33
Sophia Genetics Sa stock is traded at $5.72, with a volume of 192.52K.
It is down -5.45% in the last 24 hours and up +3.62% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$6.05
Open:
$6.13
24h Volume:
192.52K
Relative Volume:
0.86
Market Cap:
$479.88M
Revenue:
$81.18M
Net Income/Loss:
$-80.94M
P/E Ratio:
-4.8438
EPS:
-1.1809
Net Cash Flow:
$-55.15M
1W Performance:
-2.56%
1M Performance:
+3.62%
6M Performance:
+6.72%
1Y Performance:
+58.45%
1-Day Range:
$5.72
$6.315
1-Week Range:
$5.72
$6.77
52-Week Range:
$2.92
$6.77
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.72 | 479.88M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Rating of "Hold" by Brokerages - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Raised to "Hold" at Zacks Research - MarketBeat
HC Wainwright Estimates SOPHiA GENETICS Q2 Earnings - MarketBeat
$6.495 | SOPHiA GENETICS SA Ordinary Shares (SOPH) Stock Price Today - Binance
SOPHiA GENETICS (SOPH) affiliate files to sell 37,000 founders shares on NASDAQ - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighTime to Buy? - MarketBeat
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 - marketscreener.com
SOPHiA GENETICS sets 8 a.m. webcast for Q2 results call - Stock Titan
SOPHiA GENETICS: Why This AI-Powered Healthcare Stock Deserves Attention - RTTNews
SOPH insider (NASDAQ: SOPH) details planned stock and option-related sales - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeHere's What Happened - MarketBeat
H.C. Wainwright initiates Sophia Genetics stock with buy rating By Investing.com - Investing.com South Africa
HC Wainwright Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH) - MarketBeat
H.C. Wainwright initiates Sophia Genetics stock with buy rating - Investing.com
SOPHiA GENETICS prices $50M public offering at $4.75 per share - MSN
Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA - GuruFocus
Zhenyu Xu Sells 4,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $28,500.00 in Stock - MarketBeat
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $93,376.80 in Stock - MarketBeat
Tax-driven SOPHiA GENETICS (NASDAQ: SOPH) share sale under 10b5-1 plan - Stock Titan
Form 144 SOPHIA GENETICS SA For: 7 July By Investing.com - Investing.com South Africa
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $21,417.05 in Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) CEO Ross Muken Sells 9,838 Shares - MarketBeat
Jurgi Camblong Sells 22,486 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPH (NASDAQ) director sells 65,269 shares under 10b5-1 plan - Stock Titan
CFO of SOPHiA GENETICS (NASDAQ: SOPH) sells 1,592 shares for taxes - Stock Titan
SOPHiA GENETICS (SOPH) CPO sells shares to cover RSU tax withholding - Stock Titan
SOPHiA GENETICS (SOPH) CTO’s 5,285-share sale covers RSU tax via 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CSO Xu sheds 7,393 shares in tax-related Rule 10b5-1 sale - Stock Titan
[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan
SOPHiA GENETICS (SOPH) chair sells 22,486 shares under 10b5-1 tax plan - Stock Titan
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares - AOL.com
Form 144 SOPHIA GENETICS SA For: 6 July By Investing.com - Investing.com Nigeria
SOPH (NASDAQ) insider Philippe Menu reports multiple 10b5-1 sales - Stock Titan
SOPH (NASDAQ) holder ZHENYU XU lists multiple 10b5-1 sales in Form 144 - Stock Titan
SOPH (NASDAQ) insider 10b5-1 sells 4,590 shares; 1,592 RSUs planned - Stock Titan
SOPH (NASDAQ) affiliate files Form 144 to sell 9,838 RSUs; 10b5-1 trades listed - Stock Titan
Manuela Valente sells SOPH shares under 10b5-1 plan (SOPH) - Stock Titan
SOPHiA GENETICS (SOPH) Declines 3% as Stock Approaches Key Support LevelMcClellan Summation - dars.gov.et
SOPHiA GENETICS (SOPH) chair sells 83,679 shares and exercises options - Stock Titan
SOPH (NASDAQ) affiliate sells via 10b5-1; 50,069-share trade listed - Stock Titan
Form 144 SOPHIA GENETICS SA For: 29 June - Investing.com UK
Form 144 SOPHIA GENETICS SA For: 29 June By Investing.com - Investing.com South Africa
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $290,400.20 in Stock - MarketBeat
JURGI CAMBLONG (SOPH) lists 10b5-1 sales, largest 50,069 shares on 06/26/2026 - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) CEO sells 51,442 shares under Rule 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) Rises Modestly as Stock Holds Above Key Support LevelsVolume Oscillator - dars.gov.et
Enterprise value to EBIT forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBITDA forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBITDA forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.99%
2.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):